Pretreatment of Cardiac Stem Cells With Exosomes Derived From Mesenchymal Stem Cells Enhances Myocardial Repair

Cited by papers we hold 10

• Cardiac telocytes inhibit cardiac microvascular endothelial cell apoptosis through exosomal miRNA-21-5p-targeted cdip1 silencing to improve angiogenesis following myocardial infarction · 2021
  No notice
• Identifying the Therapeutic Significance of Mesenchymal Stem Cells · 2020
  No notice
• miR-132-3p priming enhances the effects of mesenchymal stromal cell-derived exosomes on ameliorating brain ischemic injury · 2020
  No notice
• MSC-Derived Exosomes-Based Therapy for Peripheral Nerve Injury: A Novel Therapeutic Strategy · 2019
  No notice
• Exosome in Cardiovascular Diseases: A Complex World Full of Hope · 2019
  No notice
• Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome · 2019
  No notice
• Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine · 2018
  No notice
• MicroRNA-132, Delivered by Mesenchymal Stem Cell-Derived Exosomes, Promote Angiogenesis in Myocardial Infarction · 2018
  No notice
• MiRNA-Sequence Indicates That Mesenchymal Stem Cells and Exosomes Have Similar Mechanism to Enhance Cardiac Repair · 2017
  No notice
• MSCs-Derived Exosomes: Cell-Secreted Nanovesicles with Regenerative Potential · 2016
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.